Health and Happiness (H&H) International Holdings Limited (HKG:1112), might not be a large cap stock, but it saw significant share price movement during recent months on the SEHK, rising to highs of HK$12.24 and falling to the lows of HK$10.22. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether Health and Happiness (H&H) International Holdings' current trading price of HK$11.20 reflective of the actual value of the small-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let's take a look at Health and Happiness (H&H) International Holdings's outlook and value based on the most recent financial data to see if there are any catalysts for a price change.
Is Health and Happiness (H&H) International Holdings Still Cheap?
Good news, investors! Health and Happiness (H&H) International Holdings is still a bargain right now according to our price multiple model, which compares the company's price-to-earnings ratio to the industry average. In this instance, we've used the price-to-earnings (PE) ratio given that there is not enough information to reliably forecast the stock's cash flows. we find that Health and Happiness (H&H) International Holdings's ratio of 8.93x is below its peer average of 13.28x, which indicates the stock is trading at a lower price compared to the Food industry. Another thing to keep in mind is that Health and Happiness (H&H) International Holdings's share price is quite stable relative to the rest of the market, as indicated by its low beta. This means that if you believe the current share price should move towards its industry peers, a low beta could suggest it is not likely to reach that level anytime soon, and once it's there, it may be hard to fall back down into an attractive buying range again.
What kind of growth will Health and Happiness (H&H) International Holdings generate?
Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Although value investors would argue that it's the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. Health and Happiness (H&H) International Holdings' earnings over the next few years are expected to increase by 44%, indicating a highly optimistic future ahead. This should lead to more robust cash flows, feeding into a higher share value.
What This Means For You
Are you a shareholder? Since 1112 is currently trading below the industry PE ratio, it may be a great time to accumulate more of your holdings in the stock. With a positive profit outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as capital structure to consider, which could explain the current price multiple.
Are you a potential investor? If you've been keeping an eye on 1112 for a while, now might be the time to make a leap. Its buoyant future profit outlook isn't fully reflected in the current share price yet, which means it's not too late to buy 1112. But before you make any investment decisions, consider other factors such as the strength of its balance sheet, in order to make a well-informed investment decision.
If you want to dive deeper into Health and Happiness (H&H) International Holdings, you'd also look into what risks it is currently facing. Be aware that Health and Happiness (H&H) International Holdings is showing 2 warning signs in our investment analysis and 1 of those is potentially serious...
If you are no longer interested in Health and Happiness (H&H) International Holdings, you can use our free platform to see our list of over 50 other stocks with a high growth potential.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.